Clinical Trial: Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579845) titled 'Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress' on April 30.

Brief Summary: The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Detoxification Inflammation Biological Aging

Intervention: DIETARY_S...